Radiolabeled heterobivalent peptidic ligands: an approach with high future potential for in vivo imaging and therapy of malignant diseases
Two-pronged synergism: We review the recently developed approach of using heterobivalent peptide ligands that interact concomitantly with different receptors on tumor cells. These ligands exhibit highly favorable tumor-targeting properties and pave the way for the development of drugs for specific,...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
05 April 2013
|
| In: |
ChemMedChem
Year: 2013, Jahrgang: 8, Heft: 6, Pages: 883-890 |
| ISSN: | 1860-7187 |
| DOI: | 10.1002/cmdc.201300081 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/cmdc.201300081 Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/cmdc.201300081 
|
| Verfasserangaben: | Gabriel Fischer, Ralf Schirrmacher, Björn Wängler, and Carmen Wängler |
| Zusammenfassung: | Two-pronged synergism: We review the recently developed approach of using heterobivalent peptide ligands that interact concomitantly with different receptors on tumor cells. These ligands exhibit highly favorable tumor-targeting properties and pave the way for the development of drugs for specific, sensitive, and noninvasive tumor imaging and therapy. |
|---|---|
| Beschreibung: | Gesehen am 31.03.2022 |
| Beschreibung: | Online Resource |
| ISSN: | 1860-7187 |
| DOI: | 10.1002/cmdc.201300081 |